Label: TRIAMCINOLONE ACETONIDE- triamcinolone acetonide ointment usp, 0.05% ointment

  • NDC Code(s): 21922-024-11
  • Packager: Encube Ethicals Private Limited
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated January 5, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. The steroids in this class include triamcinolone acetonide ...
  • CLINICAL PHARMACOLOGY
    Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various ...
  • INDICATIONS AND USAGE
    Triamcinolone Acetonide Ointment 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
  • CONTRAINDICATIONS
    Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
  • PRECAUTIONS
    General - Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-­adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and ...
  • ADVERSE REACTIONS
    The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings (reactions are listed in an ...
  • OVERDOSAGE
    Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects (see PRECAUTIONS, General).
  • DOSAGE AND ADMINISTRATION
    Apply a thin film of Triamcinolone Acetonide Ointment 0.05% to the affected area two to four times daily. Occlusive Dressing Technique - Occlusive dressings may be used for the management of ...
  • HOW SUPPLIED
    Triamcinolone Acetonide Ointment USP, 0.05%: jar containing 430 g (NDC 21922-024-11) KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.  You may report Side effects to FDA at ...
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
    PRINCIPAL DISPLAY PANEL - 430 g Jar - NDC 21922-024-11 - Triamcinolone Acetonide Ointment USP, 0.05% Rx Only - 430 g
  • INGREDIENTS AND APPEARANCE
    Product Information